Pathetic but eye opening: Opinion: The SEC never reads

New Post Public Reply Private Reply Replies (0) Message Board
AlanC WinstonNC #37147
Pathetic but eye opening:

Opinion: The SEC never reads 74% of filings, putting investors at risk

Published: Oct 28, 2015 9:59 a.m. ET
http://www.marketwatch.com/story/the-sec-neve...-28?page=2

Congressional negotiators are completing secretive work on a budget compromise. That means the Securities and Exchange Commission along with other federal agencies will soon begin receiving clearer signals about what resources they can count on. Even a best-case scenario doesn’t amount to much. But I’ll make an argument on behalf of the SEC, a government office everybody likes to kick around.

First, a reality check. Even if the SEC receives all of the $1.7 billion President Barack Obama requested, it will be only once in seven years that the agency gets around to examining every investment adviser it regulates. That’s as compared with once a decade now. Forty percent of the registered investment advisers have never been examined at all. And of 49,000 investment company filings a year, just 26% of them get read by regulators, according to the agency’s fiscal 2016 budget request.

So much for meaningful disclosure. So much for meaningful oversight.

Earlier this year, the International Monetary Fund issued the withering assessment that “the number of expert staff” at the SEC (and at the much-smaller Commodity Futures Trading Commission) “does not appear to be sufficient to ensure a robust level of hands-on supervision.” One look at the CFTC’s $322 million budget request makes that clear. “Historic underfunding of the surveillance function has dramatically and adversely impacted or compromised the commission’s ability to protect market integrity and to detect and deter manipulation,” it warns.

About 14.5% of U.S. publicly traded companies engage in fraud in any given year, with the incidence of undetected cheating about three times greater than what comes to light, according to research by finance professors Alexander Dyck, Adair Morse and Luigi Zingales. So it’s not difficult to lose heart at the idea of investor protections. Alternatively, there is much to be said for the IMF’s recommendation that the SEC and CFTC become self-funded, and subject to multi-year budgeting.

The U.S. Government Accountability Office itself says well-designed user fees—like charging for government examinations—“can reduce the burden on taxpayers.” The U.S. Mint, U.S. Patent and Trademark Office, and the Federal Communications Commission are each “fully fee-funded agencies,” according to the GAO. And the Federal Reserve System pays for its own operation, largely through income on its government securities portfolio.

Last week, the SEC reported that it had won $4.2 billion in financial disgorgements and penalties in the fiscal year ended in September, producing a nearly 3-to-1 return on the agency’s budgeted $1.5 billion. (It also collects transaction fees from the self-regulatory organizations it oversees.)

In other words, the SEC could be self-supporting, if it weren’t already turning back most of what it collects to the U.S. Treasury general fund.

The chronic underfunding of the government’s front-line securities regulators is a policy decision, rather than a fiscal one, reflecting suspicions of how much harm heavy-handed inspections, regulations and enforcement can cause to free markets. It’s another reminder that the investor is best served by being his or her own regulator, making careful, informed, self-protecting investment decisions.

Even so, a case can be made for the utility of the financial regulators.

Terrence Blackburne, a former program examiner at the White House Office of Management and Budget, obtained staffing data from the SEC’s Division of Corporation Finance, showing that when examination intensity increased in the agency’s disclosure-review office, publicly traded companies were less likely to engage in earnings management, and issued fewer financial restatements.

The calculations are complicated, and I’ll spare you the details. But Blackburne finds evidence of a “statistically significant and economically meaningful relation between SEC oversight” and the quality of corporate financial reporting.

An intriguing issue raised by Blackburne’s research—particularly in light of the inspection and examination gaps apparent in SEC oversight—is how the workload of the three-dozen disclosure specialists who oversee banks and other financial services firms is so much greater than for the other offices. (It is nearly double that of disclosure specialists devoted to natural resources, for example.)

[...]
more

http://www.marketwatch.com/story/the-sec-neve...-28?page=2

Nanotech Entertainment Inc. (NTEK) Stock Research Links

NTEK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Moore, Schulman & Moore Attorneys Earn Top Honors Again

Updated Category News Views 4

In the realm of family law, consistency in excellence matters just as much as landing a high-stakes stock trade. Moore, Schulman & Moore, APC, a San Diego family law outfit, has grabbed the spotlight yet again with nine of its ace attorneys snagging recognition from the 2027 Super Lawyers roster. A Tradition of Professional Recognition Leading the pack is Erik Moore, a...

Continue Reading
Ingram Mercantile's Aviation Push: SCORE or Sink?

Updated Category News Views 5

Unpacking Neobanx's Strategic Play Straight off the tarmac, Neobanx launches Ingram Mercantile, placing their bets on the aviation sector with none other than Eli Stepp at the helm. This ain't just another day in the sky for those in the know; it's part of a gutsy bid to inject some high-octane intelligence into the world of retail. I mean, have you seen the landscape...

Continue Reading
Zenni and Chase Stokes Foster Student Wellbeing in NYC

Updated Category News Views 3

Picture this: near 300 high schoolers milling around, glancing through shiny new glasses from the Zenni x Chase Stokes collection. In the heart of New York City, these kids are getting a double-dose of care that's all too rare—free vision screenings paired with mental health support. It's the kind of collaboration that shows you what's possible when a company, an actor,...

Continue Reading
NCICU's Digital Boost for NC Transfer Students

Updated Category News Views 4

New Platform Eases the Transfer Struggle They’ve finally cooked up something good for the college crowd in North Carolina. The NCICU, with the NCCCS, has rolled out a platform called Transfer Pathways to simplify students' path from two-year to four-year schools. This ain't just a tweak—it's backed by a hefty $2 million in grants. Hats off to those...

Continue Reading
Armor Health Strengthens Corrections Care with New Leader

Updated Category News Views 4

Fresh Blood in Correctional Healthcare Talk about stepping up where it counts! Armor Health is shaking things up, bringing in Jill Bromley as their new Regional Behavioral Health Director. The name might not ring any bells for the average Joe, but in the world of correctional healthcare, it’s like they've just upgraded from a sedan to a sports car. Armor’s game here...

Continue Reading
Helio Genomics Shakes Up Liver Cancer Detection Strategy

Updated Category News Views 5

Rethinking Liver Cancer Detection with HelioLiver Sometimes you stumble upon a tech piece that might genuinely shake up the game. Helio Genomics just poured some serious intel at the San Antonio Liver Cancer Symposium, showcasing how their HelioLiver Dx might outgun traditional scans in sniffing out hepatocellular carcinoma (HCC). They threw down four studies revealing...

Continue Reading
Elevest Unveils MADE: Shaping Wealth for Athletes, Artists

Updated Category News Views 4

Turning Talent Into Tangible Wealth Ask any musician or athlete, and they'll tell you—riding those career highs is exhilarating, but financial stability can be a different ballgame. Here comes Elevest Capital with a fresh move meant to set the players right where many falter: long-term ownership. They're rolling out MADE, a new initiative focused on flipping that burst...

Continue Reading
STRATA Showcases Excimer Laser Success in Dermatology

Updated Category News Views 4

The Cutting Edge of Skin Care: STRATA's Spotlight It's not every day you hear about dermatology shaking things up, but STRATA Skin Sciences, Inc. pulled it off with flair at the 2026 Fall Clinical Dermatology Conference in Las Vegas. For 'skin in the game,' these folks are leading the charge with their innovative excimer laser phototherapy approach, shining a fresh light...

Continue Reading
Navigating Career Growth Beyond Job Titles at Webinar

Updated Category News Views 5

Hasn't it ever struck you that job titles often fence people in like some unwanted corral, keeping potential tightly leashed? Well, here's something that might shake up your thoughts a tad. University of Phoenix is teeing up a webinar titled "Beyond The Job Title: Finding Purpose and Recognizing the Value You Bring." Scheduled for October 15, 2026, this is all about...

Continue Reading
Boliden's Q3 2026 Results: What's on the Horizon?

Updated Category News Views 3

Boliden Ready to Reveal Q3 Numbers Mark it down, folks. Thursday, October 29, 2026, is the day when Boliden's big wigs will step up to the plate and lay their cards on the table about the company's performance over the last quarter. If you've got any skin in this mining powerhouse, you'll want a front-row seat—or at least a virtual one if you're dialing in from...

Continue Reading

Top 5 Most Recently Viewed Articles

Caribou Biosciences Faces Securities Fraud Lawsuit Amid Losses

Updated Category News Views 139

Understanding the Lawsuit Against Caribou Biosciences Investors in Caribou Biosciences, Inc. (NASDAQ: CRBU) are currently facing significant challenges due to alleged misleading statements made by the company regarding its performance and product safety. A shareholder has initiated a class action lawsuit aimed at representing those who purchased CRBU securities between...

Continue Reading
BMO's Belsky Predicts Resilience of US Stocks Amid Volatility

Updated Category News Views 496

BMO's Bullish Outlook on US Stocks Brian Belsky, the Chief Investment Strategist at BMO Capital Markets, continues to maintain a positive outlook on US equities, despite the recent fluctuations in the market. His unwavering confidence comes even as the S&P 500 experiences losses in four out of the last five weeks. Belsky highlights that this downturn has been largely...

Continue Reading
How Is Pain and Suffering Calculated in Personal Injury Cases?

Updated Category Personal Finance Views 36

Pain and suffering is generally calculated by considering how an injury affects a person's physical comfort, emotional well-being, daily activities, and overall quality of life. Unlike medical bills or lost wages, these losses do not have a fixed price, so courts and insurance companies look at the nature and severity of the injury, recovery period, and long-term effects...

Continue Reading
Leap Therapeutics Showcases Financial Progress and Updates

Updated Category News Views 262

Leap Therapeutics: Financial Highlights and Updates Leap Therapeutics, Inc. (NASDAQ: LPTX), a prominent biotechnology firm dedicated to developing innovative immuno-oncology solutions, has recently revealed its financial results for the latest fiscal year. The focus today is not just on their financial performance, but also on the progress of their in-development...

Continue Reading
Tech Stocks Struggle Amid Economic Growth Concerns

Updated Category News Views 47

Current Trends Impacting Tech Stocks US tech stocks are facing significant challenges, reflecting broader worries about economic growth and the unpredictable AI market. Notably, Nvidia's shares have seen a considerable drop, highlighting the potential impacts on the technology sector. As a leading player in AI technologies, Nvidia's substantial loss in market value...

Continue Reading